The availability of advanced hematology care varies significantly by geography, with North America currently holding over 50% of the global share. However, the Immune Thrombocytopenia Market region of Asia-Pacific is identified as the fastest-growing sector. Increased healthcare spending in China and India is facilitating better access to high-cost biologics, which were previously unavailable...